1. A Phase 2a Multicenter, Double‐Blind, Placebo‐Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP‐866, 087 (a High‐Affinity Mu‐Opioid Receptor Antagonist) in Premenopausal Women Diagnosed with Female Sexual Arousal Disorder (FSAD). (24th January 2013) Authors: Orri, Miguel; Abraham, Lucy; Giraldi, Annamaria Journal: Journal of sexual medicine Issue: Volume 10:Number 10(2013:Oct.) Page Start: 2484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗